During the past decade, Hôpital Sébastopol conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hôpital Sébastopol" are "Nervous System Disorders" (2 trials), "Colorectal Cancer" (1 trials), "Extrahepatic Bile Duct Cancer" (1 trials), "Gallbladder Cancer" (1 trials) and "Leg Spasticity" (1 trials). Many other conditions were trialed in "Hôpital Sébastopol" in a lesser frequency.

Most popular intervention types in "Hôpital Sébastopol" are "Biological" (4 trials) and "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Botulinum toxin type A" (4 trials), "Placebo" (2 trials), "capecitabine" (1 trials), "cisplatin" (1 trials) and "gemcitabine hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Sébastopol" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Sébastopol". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hôpital Sébastopol, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Sébastopol, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".